Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zeniron-12 is an oral iron supplement and blood tonic developed and manufactured by Oak-Faith Pharmaceutical Resources Limited, a Nigerian pharmaceutical company. It is primarily indicated for the treatment and prevention of iron deficiency anemia and its associated symptoms, such as fatigue, dizziness, and loss of appetite. As a nutritional supplement, it provides a source of exogenous iron to replenish depleted systemic stores, thereby supporting the synthesis of hemoglobin and improving oxygen transport in the blood. The product is marketed as an over-the-counter (OTC) tonic for nutritional support and general wellness in cases of nutritional anemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zeniron-12.